These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

695 related items for PubMed ID: 3918102

  • 1. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH, Hooks JJ, Quinnan GV, Lane HC, Manischewitz JF, Macher AM, Masur H, Fauci AS, Djeu JY.
    J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2.
    Bonavida B, Katz J, Gottlieb M.
    J Immunol; 1986 Aug 15; 137(4):1157-63. PubMed ID: 3488345
    [Abstract] [Full Text] [Related]

  • 3. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ, Ronteltap CP, Gravekamp C, Monnikendam D, Bolhuis RL.
    J Immunol; 1986 Mar 01; 136(5):1700-7. PubMed ID: 3005399
    [Abstract] [Full Text] [Related]

  • 4. Immunomodulating effects in vitro of interleukin-2 and interferon-gamma on human blood and bone marrow mononuclear cells.
    Kedar E, Rezai AR, Giorgi JV, Gale RP, Champlin RE, Mitsuyasu RT, Fahey JL.
    Nat Immun Cell Growth Regul; 1988 Mar 01; 7(1):13-30. PubMed ID: 2896298
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD, Mitsuyasu R, Gottlieb MS, Lebow LT, Bonavida B.
    J Immunol; 1987 Jul 01; 139(1):55-60. PubMed ID: 3584988
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development.
    Ueno Y, Miyawaki T, Seki H, Matsuda A, Taga K, Sato H, Taniguchi N.
    J Immunol; 1985 Jul 01; 135(1):180-4. PubMed ID: 3923100
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of interferon-alpha 2 and interleukin-2 on natural killer cell activity in patients with acquired immune deficiency syndrome.
    Reddy MM, Chinoy P, Grieco MH.
    J Biol Response Mod; 1984 Aug 01; 3(4):379-86. PubMed ID: 6332880
    [Abstract] [Full Text] [Related]

  • 8. Natural killer activity in cloned cytotoxic T lymphocytes: regulation by interleukin 2, interferon, and specific antigen.
    Brooks CG, Holscher M, Urdal D.
    J Immunol; 1985 Aug 01; 135(2):1145-52. PubMed ID: 2409140
    [Abstract] [Full Text] [Related]

  • 9. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR, Mason AT, Gerard JP, Henderson LE, Farrar W, Hopkins RF, Herberman RB, Rabin H.
    J Immunol; 1984 Aug 01; 133(2):779-83. PubMed ID: 6203980
    [Abstract] [Full Text] [Related]

  • 10. Regulation of human natural killer cell activity by interferon-gamma: lack of a role in interleukin 2-mediated augmentation.
    Sayers TJ, Mason AT, Ortaldo JR.
    J Immunol; 1986 Mar 15; 136(6):2176-80. PubMed ID: 3081640
    [Abstract] [Full Text] [Related]

  • 11. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production.
    Handa K, Suzuki R, Matsui H, Shimizu Y, Kumagai K.
    J Immunol; 1983 Feb 15; 130(2):988-92. PubMed ID: 6294182
    [Abstract] [Full Text] [Related]

  • 12. Augmentation of human natural cell-mediated cytotoxicity by recombinant human interleukin 2.
    Svedersky LP, Shepard HM, Spencer SA, Shalaby MR, Palladino MA.
    J Immunol; 1984 Aug 15; 133(2):714-8. PubMed ID: 6203975
    [Abstract] [Full Text] [Related]

  • 13. Natural cytotoxic activity in multiple sclerosis patients: defects in IL-2/interferon gamma-regulatory circuit.
    Braakman E, van Tunen A, Meager A, Lucas CJ.
    Clin Exp Immunol; 1986 Nov 15; 66(2):285-94. PubMed ID: 2949897
    [Abstract] [Full Text] [Related]

  • 14. Absence of responsiveness to interferon-gamma but not to interleukin 2 and depressed recycling as natural killer cell abnormalities in childhood lymphohistiocytic syndrome.
    Yang FC, Yabuhara A, Koike K.
    Int J Hematol; 1994 Jun 15; 59(4):273-80. PubMed ID: 8086621
    [Abstract] [Full Text] [Related]

  • 15. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).
    Itoh K, Shiiba K, Shimizu Y, Suzuki R, Kumagai K.
    J Immunol; 1985 May 15; 134(5):3124-9. PubMed ID: 2984283
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer.
    Hunter CA, Timans J, Pisacane P, Menon S, Cai G, Walker W, Aste-Amezaga M, Chizzonite R, Bazan JF, Kastelein RA.
    Eur J Immunol; 1997 Nov 15; 27(11):2787-92. PubMed ID: 9394800
    [Abstract] [Full Text] [Related]

  • 17. Interleukin (IL)-2 deficiency aggravates the defect of natural killer cell activity in AIDS patients.
    Zerhouni B, Sanhadji K, Kehrli L, Livrozet JM, Touraine JL.
    Thymus; 1997 Nov 15; 24(3):147-56. PubMed ID: 9151380
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
    Hafner M, Falk W, Echtenacher B, Männel DN.
    Eur Cytokine Netw; 1999 Dec 15; 10(4):541-8. PubMed ID: 10586121
    [Abstract] [Full Text] [Related]

  • 19. Defective NK cell activity following thermal injury.
    Klimpel GR, Herndon DN, Fons M, Albrecht T, Asuncion MT, Chin R, Stein MD.
    Clin Exp Immunol; 1986 Nov 15; 66(2):384-92. PubMed ID: 3493101
    [Abstract] [Full Text] [Related]

  • 20. Interferon-gamma induction by lipopolysaccharide: dependence on interleukin 2 and macrophages.
    Blanchard DK, Djeu JY, Klein TW, Friedman H, Stewart WE.
    J Immunol; 1986 Feb 01; 136(3):963-70. PubMed ID: 2867114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.